Related Experiment Video
Updated: Jul 7, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
[Orphan diseases: evaluations of new treatments]
J F Bergmann1, V Delcey, K Champion
1Service de Médecine Interne A, Hôpital Lariboisière, 2, rue Ambroise Paré, 75475 Paris 10, France. jf.bergmann@lrb.aphp.fr
Abstract:
The new treatments of orphan diseases must be assessed according to the methodologic rules of therapeutic trials, in order to ensure clinically and statistically significant evaluations: randomized controled trials, single primary end-point, statistically significant and clinically relevant efficience. Although these rules may be relaxed in orphan diseases, they have to maintain the standard of therapeutic efficiency.
Insights
New orphan disease treatments require rigorous evaluation using therapeutic trial methods like randomized controlled trials. Ensuring clinical and statistical significance is crucial for valid efficiency assessments, even with relaxed rules.
Area of Science:
- Medical Research
- Clinical Trials
- Rare Diseases
Background:
- Orphan diseases affect a small patient population, posing unique challenges for clinical research.
- Traditional therapeutic trial methodologies are essential for evaluating new treatments.
Purpose of the Study:
- To outline the methodological standards for assessing new orphan disease treatments.
- To emphasize the importance of rigorous evaluation for therapeutic efficiency.
Main Methods:
- Adherence to established therapeutic trial rules, including randomized controlled trials.
- Defining a single primary endpoint for clear outcome measurement.
- Ensuring statistically significant and clinically relevant efficacy.
Main Results:
- Methodological rules for therapeutic trials are critical for orphan disease treatment evaluation.
- While some rules may be adapted, the standard of therapeutic efficiency must be maintained.
Conclusions:
- Rigorous evaluation of orphan disease treatments is paramount.
- Therapeutic trial standards ensure the reliability and validity of treatment efficacy data.
Related Concept Videos
Treatment Resistant Cancers
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Treatment Resistent Cancers
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacogenomics: Identification of New Drug Targets
Gene Therapy
